Implications of prescription drug monitoring and medical cannabis legislation on opioid overdose mortality

Canna Clinical TrialsLeave a comment

Ecological study estimating opioid-related mortality in states with and without a prescription drug monitoring program (PDMP) and/or medical cannabis legislation. The relationship between PDMPs with mandatory access provisions, medical cannabis legislation, and opioid-related mortality rates. When combined with the availability of medical cannabis as an alternative analgesic therapy, PDMPs may be more effective at decreasing opioid-related mortality.

Associations between medical cannabis and other drug use among unstably housed women

Canna Clinical TrialsLeave a comment

Several studies suggest that U.S. state-level legalization of cannabis for medical purposes may be associated with reductions in opioid use; yet its relationship with stimulant use, particularly in high-risk populations like unstably housed women, has received less attention. Associations between use of cannabis and “street drugs” depend on whether the cannabis is obtained through a medical context. Interventions, research, and policy considering the influence of cannabis on the use of other drugs may benefit by distinguishing between medical and non-medical cannabis use.